Milestone Pharmaceuticals Ownership | Who Owns Milestone Pharmaceuticals?

Milestone Pharmaceuticals Ownership Summary

Milestone Pharmaceuticals is owned by 43.28% institutional investors, 0.69% insiders, and 56.03% retail investors. Blackrock is the largest institutional shareholder, holding 9.91% of MIST shares. Biotech Growth Ord is the top mutual fund, with 1.81% of its assets in Milestone Pharmaceuticals shares.

MIST Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Milestone Pharmaceuticals	43.28%	0.69%	56.03%
Sector	Healthcare Stocks	46.62%	8.13%	45.25%
Industry	Biotech Stocks	44.91%	7.98%	47.11%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	4.97M	9.91%	$6.56M
Rtw investments, lp	3.26M	6.49%	$4.30M
Millennium management	2.75M	5.48%	$3.66M
Alta fundamental advisers	2.66M	5.30%	$3.51M
Lion point capital, lp	2.34M	4.67%	$3.09M
Orbimed advisors	2.00M	3.99%	$2.64M
Nantahala capital management	1.75M	3.49%	$2.31M
Goldman sachs group	1.35M	2.70%	$1.79M
Bleichroeder lp	1.33M	2.64%	$1.75M
Stonepine capital management	1.24M	2.47%	$1.64M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Lion point capital, lp	2.34M	5.63%	$3.09M
Stonepine capital management	1.24M	1.49%	$1.64M
Alta fundamental advisers	2.66M	1.11%	$3.51M
Bml capital management	1.10M	1.04%	$1.46M
Altium capital management lp	1.01M	0.55%	$1.34M
Bleichroeder lp	1.33M	0.52%	$1.75M
Nantahala capital management	1.75M	0.14%	$2.31M
Ikarian capital	466.02K	0.11%	$619.81K
Rtw investments, lp	3.26M	0.07%	$4.30M
Orbimed advisors	2.00M	0.05%	$2.64M

Top Buyers

Holder	Shares	% Assets	Change
Bml capital management	1.10M	1.04%	496.75K
Alta fundamental advisers	2.66M	1.11%	287.30K
Squarepoint ops	54.68K	0.00%	54.68K
Lion point capital, lp	2.34M	5.63%	40.00K
Atria investments	27.99K	0.00%	27.99K

Top Sellers

Holder	Shares	% Assets	Change
Velan capital investment management lp	-	-	-650.00K
Monashee investment management	-	-	-500.00K
Bank of montreal /can/	-	-	-273.10K
Stonepine capital management	1.24M	1.49%	-223.10K
Altium capital management lp	1.01M	0.55%	-200.51K

New Positions

Holder	Shares	% Assets	Change	Value
Squarepoint ops	54.68K	0.00%	54.68K	$72.73K
Atria investments	27.99K	0.00%	27.99K	$36.95K
Susquehanna group, llp	16.90K	-	16.90K	$22.48K
Jones financial companies lllp	1.07K	-	1.07K	$1.41K

Sold Out

Holder	Change
Qube research	-194.00
Ica group wealth management	-200.00
Ubs group	-2.62K
Citadel advisors	-3.50K
Xtx topco	-13.40K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	41	-	28,647,040	-5.08%	43	1.20%	13	-	8	33.33%
Jun 30, 2024	41	-6.82%	30,178,631	-3.74%	60	1.13%	13	-48.00%	6	20.00%
Mar 31, 2024	44	4.76%	31,351,699	76.28%	72	4.26%	25	56.25%	5	-50.00%
Dec 31, 2023	42	5.00%	17,784,737	-8.16%	41	2.03%	16	45.45%	10	-28.57%
Sep 30, 2023	40	-18.37%	19,364,922	-5.45%	45	1.97%	11	-52.17%	14	16.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Biotech Growth Ord	963.40K	1.81%	-
LUNIS Biotech Growth Opp Fd I a	26.90K	0.05%	-
SPDR® S&P® International Small Cap ETF	19.12K	0.04%	-
Fidelity Nasdaq Composite Index	17.58K	0.03%	-
Dimensional Global Core Equity USD Acc	5.85K	0.01%	-15.00
Dimensional Global Small Coms USD Acc	5.00K	0.01%	-13.00
Dimensional World Equity GBP Acc	3.65K	0.01%	-
Dimensional Global Sust Cor Eq USD Acc	2.69K	0.01%	-7.00
Dimensional World Allc 60/40 GBP Acc	2.60K	0.00%	-2.00
JNL/DFA US Small Cap A	1.66K	0.00%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 01, 2022	Bharucha David	Chief Medical Officer	Buy	$14.58K
Dec 05, 2022	Bharucha David	Chief Medical Officer	Buy	$32.83K
Oct 19, 2022	Wills Robert James	-	Buy	$73.95K
Oct 20, 2022	Pasternak Richard C	-	Buy	$52.00K
Oct 20, 2022	Liebert Debra K.	-	Buy	$52.90K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	-
2023 Q2	-	-
2023 Q1	-	-
2022 Q4	7	-
2022 Q3	2	2

MIST Ownership FAQ

Who Owns Milestone Pharmaceuticals?

Milestone Pharmaceuticals shareholders are primarily institutional investors at 43.28%, followed by 0.69% insiders and 56.03% retail investors. The average institutional ownership in Milestone Pharmaceuticals's industry, Biotech Stocks , is 44.91%, which Milestone Pharmaceuticals falls below.

Who owns the most shares of Milestone Pharmaceuticals?

Milestone Pharmaceuticals’s largest shareholders are Blackrock (4.97M shares, 9.91%), Rtw investments, lp (3.26M shares, 6.49%), and Millennium management (2.75M shares, 5.48%). Together, they hold 21.89% of Milestone Pharmaceuticals’s total shares outstanding.

Does Blackrock own Milestone Pharmaceuticals?

Yes, BlackRock owns 9.91% of Milestone Pharmaceuticals, totaling 4.97M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 6.56M$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Milestone Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Lion point capital, lp is Milestone Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 5.63% of its assets in 2.34M Milestone Pharmaceuticals shares, valued at 3.09M$.

Who is the top mutual fund holder of Milestone Pharmaceuticals shares?

Biotech Growth Ord is the top mutual fund holder of Milestone Pharmaceuticals shares, with 1.81% of its total shares outstanding invested in 963.4K Milestone Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools